Health Sciences

Training China’s Next Generation of Dentists

Penn’s multitude of rapidly growing China connections can be viewed through a number of different prisms. Some focus on its manufacturing networks or banking system. Others see it in terms of civil engineering challenges or consumer purchasing trends.

Penn Study Adapts Proven Community Health Worker Model for Outpatient Setting

Penn's Innovative Community Health Worker (CHW) model, shown to reduce admissions and lead to better health outcomes for hospitalized patients, can now be used in outpatient settings, according to a study from researchers at the Perelman School of Medicine in the journalPopulation Health Management.

Greg Richter

Penn Researchers Identify a New Cause of Inherited Neuropathy

Charcot-Marie-Tooth Disease (CMT) is a family of inherited disorders of the peripheral nervous system, affecting approximately one in 2,500 Americans. Its most common iteration, CMT1, comes in many forms, most of which have to date been linked to a small set of causative genes.

Lee-Ann Donegan

Genomes of Chimpanzee Parasite Species Reveal Evolution of Human Malaria, According to Penn-led Study

Understanding the origins of emerging diseases – as well as more established disease agents -- is critical to gauge future human infection risks and find new treatment and prevention approaches. This holds true for malaria, which kills more than 500,000 people a year. Symptoms, including severe anemia, pregnancy-associated malaria, and cerebral malaria, have been linked to the parasite’s ability to cause infected red blood cells to bind to the inner lining of blood vessels.

Karen Kreeger

Penn, University of Michigan VA-led Study: Antipsychotic Drugs Linked to Increased Mortality Among Parkinson's Disease Patients

At least half of Parkinson’s disease patients experience psychosis at some point during the course of their illness, and physicians commonly prescribe antipsychotic drugs, such as quetiapine, to treat the condition. However, a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, the University of Michigan Medical School, and the Philadelphia and Ann Arbor Veterans Affairs (VA) Medical Centers and suggests that these drugs may do significantly more harm in a subset of patients. The findings will be published in the March 21 issue of JAMA Neurology.

Lee-Ann Donegan

Penn Biochemist Receives Protein Society Award

Benjamin Aaron Garcia, PhD, a Presidential Professor of Biochemistry and Biophysics at the Perelman School of Medicine at the University of Pennsylvania, has been selected to receive the 2016Protein Science Young Investigator Award.

Karen Kreeger



In the News


Slate.com

What’s going on with tranq?

Jeanmarie Perron of the Perelman School of Medicine says that the appearance and progression of skin ulcers and tissue loss on xylazine users is different than with other intravenous drugs.

FULL STORY →



The Hill

It’s time to end the Medicare-Medicaid merry-go-round

In an opinion essay, Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that Medicare and Medicaid fail to integrate coverage and coordinate care across their two plans.

FULL STORY →



The Wall Street Journal

The quest for treatments to keep weight off after Ozempic

Researchers at Penn are conducting a co-authored study of the brains, fat and muscle cells, and eating patterns of people trying to maintain new body sizes.

FULL STORY →



Philadelphia Inquirer

Inside Penn’s transfer center

Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.

FULL STORY →



Philadelphia Inquirer

Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use

Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.

FULL STORY →